Page 17 - Read Online
P. 17

Schiemann. J Cancer Metastasis Treat 2020;6:3  I  http://dx.doi.org/10.20517/2394-4722.2020.01                             Page 3 of 4

               Conflicts of interest
               The author declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.

               REFERENCES
               1.   Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and
                   mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
               2.   Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011;331:1559-64.
               3.   Fidler IJ, Kripke ML. The challenge of targeting metastasis. Cancer Metastasis Rev 2015;34:635-41.
               4.   Klein CA. Framework models of tumor dormancy from patient-derived observations. Curr Opin Genet Dev 2011;21:42-9.
               5.   DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, et al. Breast cancer statistics, 2019. CA Cancer J Clin 2019;69:438-51.
               6.   Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell 2017;168:670-91.
               7.   Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol
                   2010;28:3271-7.
               8.   Vanharanta S, Massague J. Origins of metastatic traits. Cancer Cell 2013;24:410-21.
               9.   Parvani JG, Taylor MA, Schiemann WP. Noncanonical TGF-b signaling during mammary tumorigenesis. J Mammary Gland Biol Neoplasia
                   2011;16:127-46.
               10.  Darbre PD. The potential for estrogen disrupting chemicals to contribute to migration, invasion and metastasis of human breast cancer cells.
                   J Cancer Metastasis Treat 2019;5:58.
               11.  Lei JT, Gou X, Seker S, Ellis MJ. ESR1 alterations and metastasis in estrogen receptor positive breast cancer. J Cancer Metastasis Treat
                   2019;5:38.
               12.  Anstine LJ, Keri RA. A new view of the mammary epithelial hierarchy and its implications for breast cancer initiation and metastasis. J
                   Cancer Metastasis Treat 2019;5:50.
               13.  Smigiel JM, Taylor SE, Bryson BL, Tamagno I, Polak K, et al. Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant
                   problem. J Cancer Metastasis Treat 2019;5:47.
               14.  Robinson NJ, Taylor DJ, Schiemann WP. Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere
                   maintenance mechanisms and metastatic evolution. J Cancer Metastasis Treat 2019;5:39.
               15.  Sacca CD, Gorini F, Ambrosio S, Amente S, Majello B. Targeting histone lysine-specific demethylase KDM1A/LSD1 to control epithelial-
                   mesenchymal transition program in breast cancers. J Cancer Metastasis Treat 2019;5:15.
               16.  Grelet S, Howe PH. hnRNP E1 at the crossroads of translational regulation of epithelial-mesenchymal transition. J Cancer Metastasis Treat
                   2019;5:16.
               17.  Meng X, Yang S, Zhang J, Yu H. Contribution of alternative splicing to breast cancer metastasis. J Cancer Metastasis Treat 2019;5:21.
               18.  Maisel SA, Schroeder J. Wrong place at the wrong time: how retrograde trafficking drives cancer metastasis through receptor
                   mislocalization. J Cancer Metastasis Treat 2019;5:7.
               19.  Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
               20.  Li F, Tiede B, Massague J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 2007;17:3-14.
               21.  Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, et al. Critical research gaps and translational priorities for the successful prevention
                   and treatment of breast cancer. Breast Cancer Res 2013;15:R92.
               22.  Flynn AB, Schiemann WP. Autophagy in breast cancer metastatic dormancy: Tumor suppressing or tumor promoting functions? J Cancer
                   Metastasis Treat 2019;5:43.
               23.  Gooding AJ, Parker KA, Valadkhan S, Schiemann WP. The lncRNA BORG: a novel inducer of TNBC metastasis, chemoresistance, and
                   disease recurrence. J Cancer Metastasis Treat 2019;5:41.
               24.  Place AE, Jin Huh S, Polyak K. The microenvironment in breast cancer progression: biology and implications for treatment. Breast Cancer
                   Res 2011;13:227.
               25.  Mizejewski GJ. Breast cancer, metastasis, and the microenvironment: disabling the tumor cell-to-stroma communication network. J Cancer
                   Metastasis Treat 2019;5:35.
               26.  Wallace TR, Tarullo SE, Crump LS, Lyons TR. Studies of postpartum mammary gland involution reveal novel pro-metastatic mechanisms.
                   J Cancer Metastasis Treat 2019;5:9.
               27.  Borniger JC. Central regulation of breast cancer growth and metastasis. J Cancer Metastasis Treat 2019;5:23.
               28.  Kamal NH, El-Amrawy F, Ali HA, Edafiogho I, Nounou MI. Is active targeting of brain metastases of breast cancer superior to passive
                   targeting? J Cancer Metastasis Treat 2019;5:23.
   12   13   14   15   16   17   18   19   20   21   22